Status:
COMPLETED
This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry
Lead Sponsor:
Pfizer
Conditions:
Arthritis, Rheumatoid
Eligibility:
All Genders
18+ years
Brief Summary
This is a retrospective observational study looking at the characteristics and outcomes of participants taking Inflectra using the CorEvitas Rheumatoid Arthritis Registry.
Eligibility Criteria
Inclusion
- Be at least 18 years of age
- Have been diagnosed with RA by a rheumatologist
- Have initiated treatment with Inflectra
- Had assessment of effectiveness in patients who have at least one follow up visit.
Exclusion
- No additional exclusion criteria
Key Trial Info
Start Date :
November 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 11 2022
Estimated Enrollment :
255 Patients enrolled
Trial Details
Trial ID
NCT05375942
Start Date
November 11 2022
End Date
November 11 2022
Last Update
April 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer
Collegeville, Pennsylvania, United States, 19426